Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Corum Group Limited ( (AU:PHX) ) has shared an announcement.
Pharmx Technologies has renewed its National Diabetes Services Scheme (NDSS) agreement for another year, maintaining the same terms and securing its role in national health service delivery. This renewal strengthens Pharmx’s position as a key player in pharmacy operations, ensuring continued support for its extensive network and reinforcing its commitment to healthcare service delivery across Australia and New Zealand.
More about Corum Group Limited
Pharmx Technologies Ltd. is the leading pharmacy ordering platform in Australia and New Zealand, offering essential technology infrastructure for seamless ordering and inventory management. The company connects a vast network of pharmacies, suppliers, and technology vendors, facilitating approximately $20 billion in transactions annually. Pharmx is positioned for sustained growth, leveraging its extensive network, proprietary pharma-tech, and advanced data capabilities to enhance healthcare outcomes across the region.
Average Trading Volume: 670,951
Technical Sentiment Signal: Buy
Current Market Cap: A$53.87M
For an in-depth examination of PHX stock, go to TipRanks’ Overview page.